tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HALO Stock Latest News

Halozyme price target raised to $90 from $75 at Benchmark
The FlyHalozyme price target raised to $90 from $75 at Benchmark
3d ago
MRK
HALO
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Amid Patent Challenges
PremiumRatings
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating Amid Patent Challenges
3d ago
HALO
Halozyme price target raised to $85 from $75 at H.C. Wainwright
PremiumThe Fly
Halozyme price target raised to $85 from $75 at H.C. Wainwright
5d ago
HALO
Halozyme price target raised to $80 from $75 at Morgan Stanley
PremiumThe Fly
Halozyme price target raised to $80 from $75 at Morgan Stanley
1M ago
HALO
Halozyme’s Strong Financial Performance and Growth Potential Justifies Buy Rating
PremiumRatings
Halozyme’s Strong Financial Performance and Growth Potential Justifies Buy Rating
1M ago
HALO
Halozyme Therapeutics’ Earnings Call Highlights Robust Growth
PremiumCompany AnnouncementsHalozyme Therapeutics’ Earnings Call Highlights Robust Growth
2M ago
HALO
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating and Increased Price Target
Premium
Ratings
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating and Increased Price Target
2M ago
HALO
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating
Premium
Ratings
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating
2M ago
HALO
Halozyme price target raised to $75 from $72 at H.C. Wainwright
PremiumThe Fly
Halozyme price target raised to $75 from $72 at H.C. Wainwright
2M ago
HALO
Halozyme upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Halozyme upgraded to Overweight from Equal Weight at Morgan Stanley
2M ago
HALO
Halozyme Therapeutics Reports Strong Q2 2025 Results
PremiumCompany Announcements
Halozyme Therapeutics Reports Strong Q2 2025 Results
2M ago
HALO
Positive Outlook and Strong Performance Drive Buy Rating for Halozyme
PremiumRatings
Positive Outlook and Strong Performance Drive Buy Rating for Halozyme
2M ago
HALO
Halozyme reports Q2 non-GAAP EPS $1.54, consensus $1.23
PremiumThe FlyHalozyme reports Q2 non-GAAP EPS $1.54, consensus $1.23
2M ago
HALO
Halozyme raises FY25 non-GAAP EPS view to $6.00-$6.40 from $5.30-$5.70
Premium
The Fly
Halozyme raises FY25 non-GAAP EPS view to $6.00-$6.40 from $5.30-$5.70
2M ago
HALO
Halozyme Therapeutics (HALO) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Halozyme Therapeutics (HALO) Q2 Earnings Cheat Sheet
2M ago
HALO
Halozyme’s Promising Cancer Study: A Potential Game-Changer in Oncology
PremiumCompany Announcements
Halozyme’s Promising Cancer Study: A Potential Game-Changer in Oncology
2M ago
HALO
Halozyme says EU approves new indication for Janssen’s Darzalex Faspro
PremiumThe Fly
Halozyme says EU approves new indication for Janssen’s Darzalex Faspro
2M ago
JNJ
HALO
Hold Rating for Halozyme Amid CMS Pricing Uncertainty and Regulatory Concerns
PremiumRatings
Hold Rating for Halozyme Amid CMS Pricing Uncertainty and Regulatory Concerns
2M ago
HALO
Halozyme resumed with a Neutral at Goldman Sachs
PremiumThe Fly
Halozyme resumed with a Neutral at Goldman Sachs
3M ago
HALO
Closing Bell Movers: Progress Software slips 4% after earnings
PremiumThe FlyClosing Bell Movers: Progress Software slips 4% after earnings
3M ago
CXW
DYN
Halozyme added to Russell 1000 Index
Premium
The Fly
Halozyme added to Russell 1000 Index
3M ago
HALO
Halozyme says Argenx received EU approval for Vyvgart with Enhanze for CIDP
Premium
The Fly
Halozyme says Argenx received EU approval for Vyvgart with Enhanze for CIDP
3M ago
ARGX
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >